# Abbott Laboratories (ABT) — Q2-2022 Earnings Results

**Report date:** 2022-07-20 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q2-2022

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Down 1.55%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.43 | N/A | +34.15% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Abbott Laboratories reported a strong earnings per share, beating expectations significantly. However, the stock declined by 1.55% following the announcement. This reaction may indicate investor concerns or uncertainty despite the positive EPS surprise.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q2-2022_